Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targin in Korean Patients With Spinal Disorders
NCT01811238Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Sep 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of oxycodone in Spinal pain, sponsored by Mundipharma. Primary endpoint: Change From Baseline in Pain Intensity of Patient With Spinal Disorder as Measured by NRS at 8 weeks. Started Sep 2012; status: completed.
02
Drugs
oxycodone
03
Conditions
Spinal pain
Beyond the preview
Go deeper on NCT01811238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811238.